A detailed history of State Of Wyoming transactions in I Teos Therapeutics, Inc. stock. As of the latest transaction made, State Of Wyoming holds 3,320 shares of ITOS stock, worth $28,087. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,320
Holding current value
$28,087
% of portfolio
0.0%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$10.09 - $17.97 $33,498 - $59,660
3,320 New
3,320 $33,000
Q1 2023

May 12, 2023

BUY
$13.02 - $22.62 $19,920 - $34,608
1,530 Added 33.8%
6,056 $82,000
Q4 2022

Feb 14, 2023

BUY
$17.77 - $21.6 $2,683 - $3,261
151 Added 3.45%
4,526 $88,000
Q3 2022

Nov 14, 2022

BUY
$18.6 - $27.25 $68,001 - $99,626
3,656 Added 508.48%
4,375 $83,000
Q2 2022

Aug 15, 2022

BUY
$16.57 - $35.1 $11,748 - $24,885
709 Added 7090.0%
719 $15,000
Q1 2022

May 13, 2022

BUY
$31.92 - $47.45 $63 - $94
2 Added 25.0%
10 $0
Q4 2021

Feb 11, 2022

SELL
$26.23 - $47.86 $26 - $47
-1 Reduced 11.11%
8 $0
Q3 2021

Feb 11, 2022

SELL
$23.91 - $29.58 $95 - $118
-4 Reduced 30.77%
9 $0
Q2 2021

Feb 11, 2022

BUY
$17.9 - $36.1 $125 - $252
7 Added 116.67%
13 $0
Q1 2021

Feb 08, 2022

BUY
$30.86 - $44.2 $185 - $265
6 New
6 $0

Others Institutions Holding ITOS

About iTeos Therapeutics, Inc.


  • Ticker ITOS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 35,575,300
  • Market Cap $301M
  • Description
  • Iteos Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients. The company's product pipeline includes inupadenant, a small molecule antagonist of the adenosine A2AR antagonists that is in Phase 2 clinical trials; and EOS-448, an antagonist of TIGIT or ...
More about ITOS
Track This Portfolio

Track State Of Wyoming Portfolio

Follow State Of Wyoming and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Wyoming, based on Form 13F filings with the SEC.

News

Stay updated on State Of Wyoming with notifications on news.